Cargando…

Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)

AIM: Familial hypercholesterolemia (FH) patients are at high risk for premature coronary heart disease (CHD). Despite the use of statins, most patients do not achieve an optimal LDL-cholesterol goal. The aims of this study are to describe baseline characteristics and to evaluate Lipid Lowering Thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mata, Nelva, Alonso, Rodrigo, Badimón, Lina, Padró, Teresa, Fuentes, Francisco, Muñiz, Ovidio, Perez-Jiménez, Francisco, López-Miranda, José, Díaz, Jose L, Vidal, Jose I, Barba, A, Piedecausa, Mar, Sanchez, Juan F, Irigoyen, Luis, Guallar, Eliseo, Ordovas, José M, Mata, Pedro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141550/ https://www.ncbi.nlm.nih.gov/pubmed/21663647 http://dx.doi.org/10.1186/1476-511X-10-94

Ejemplares similares

Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study
por: Pérez de Isla, Leopoldo, et al.
Publicado: (2023)

Diagnóstico y tratamiento de la hipercolesterolemia familiar en España: documento de consenso()
por: Mata, Pedro, et al.
Publicado: (2015)

Macrophages of genetically characterized familial hypercholesterolaemia patients show up‐regulation of LDL‐receptor‐related proteins
por: Escate, Rafael, et al.
Publicado: (2016)

Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient Care
por: Alonso, Rodrigo, et al.
Publicado: (2020)

A genetic variant in the LDLR promoter is responsible for part of the LDL-cholesterol variability in primary hypercholesterolemia
por: De Castro-Orós, Isabel, et al.
Publicado: (2014)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

LDL-Induced Impairment of Human Vascular Smooth Muscle Cells Repair Function Is Reversed by HMG-CoA Reductase Inhibition
por: Padró, Teresa, et al.
Publicado: (2012)

R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study
por: Criado-García, Juan, et al.
Publicado: (2011)

Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia
por: Climent, Elisenda, et al.
Publicado: (2017)

Association of Achilles tendon thickness and LDL-cholesterol levels in patients with hypercholesterolemia
por: Wang, Bei, et al.
Publicado: (2018)

Myeloperoxidase modulation by LDL apheresis in Familial Hypercholesterolemia
por: Puntoni, Mariarita, et al.
Publicado: (2011)

Hypercholesterolemia-Induced HDL Dysfunction Can Be Reversed: The Impact of Diet and Statin Treatment in a Preclinical Animal Model
por: Schoch, Leonie, et al.
Publicado: (2022)

Serum Selenium Concentrations and Diabetes in U.S. Adults: National Health and Nutrition Examination Survey (NHANES) 2003–2004
por: Laclaustra, Martin, et al.
Publicado: (2009)

The Role of Cumulative LDL Cholesterol in Cardiovascular Disease Development in Patients with Familial Hypercholesterolemia
por: Korneva, Victoria, et al.
Publicado: (2022)

Rationale and design of the SafeHeart study: Development and testing of a mHealth tool for the prediction of arrhythmic events and implantable cardioverter-defibrillator therapy
por: Frodi, Diana M., et al.
Publicado: (2021)

Prevalence and Impact of Apolipoprotein E7 on LDL Cholesterol Among Patients With Familial Hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2021)

PCSK9 Functions in Atherosclerosis Are Not Limited to Plasmatic LDL-Cholesterol Regulation
por: Luquero, Aureli, et al.
Publicado: (2021)

HDL Function and Size in Patients with On-Target LDL Plasma Levels and a First-Onset ACS
por: Cordero, Alberto, et al.
Publicado: (2023)

Trends in Qualifying Biomarkers in Drug Safety. Consensus of the 2011 Meeting of the Spanish Society of Clinical Pharmacology
por: Agúndez, José A. G., et al.
Publicado: (2012)

Phenotypic and Genetic Characterization of Lower LDL Cholesterol and Increased Type 2 Diabetes Risk in the UK Biobank
por: Klimentidis, Yann C., et al.
Publicado: (2020)

HELP LDL Apheresis Reduces Plasma Pentraxin 3 in Familial Hypercholesterolemia
por: Zanetti, Michela, et al.
Publicado: (2014)

Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia
por: Varga, Viktória E., et al.
Publicado: (2016)

Antioxidized LDL Antibodies Are Associated With Different Metabolic Pathways in Patients With Atherosclerotic Plaque and Type 2 Diabetes
por: Bernal-Lopez, M. Rosa, et al.
Publicado: (2013)

Alternative C3 Complement System: Lipids and Atherosclerosis
por: Garcia-Arguinzonis, Maisa, et al.
Publicado: (2021)

Vitamin D status and hypercholesterolemia in Spanish general population
por: Cutillas-Marco, Eugenia, et al.
Publicado: (2013)

Application of IoT in Healthcare: Keys to Implementation of the Sustainable Development Goals
por: Verdejo Espinosa, Ángeles, et al.
Publicado: (2021)

Loss-of-function mutation of PCSK9 as a protective factor in the clinical expression of familial hypercholesterolemia: A case report
por: Bayona, Ane, et al.
Publicado: (2020)

Treatment patterns and use of healthcare resources of patients with atherosclerotic cardiovascular disease and hypercholesterolemia and patients with familial hypercholesterolemia in Spain: Protocol of the Reality study
por: Barrios, Vivencio, et al.
Publicado: (2022)

Reporting LDL cholesterol results by clinical biochemistry laboratories in Czechia and Slovakia to improve the detection rate of familial hypercholesterolemia
por: Šálek, Tomáš, et al.
Publicado: (2023)

Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)
por: Sánchez-Guijo, Fermín, et al.
Publicado: (2023)

Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis
por: Badimon, Lina, et al.
Publicado: (2016)

Data related to inflammation and cholesterol deposition triggered by macrophages exposition to modified LDL
por: Toledo, Juan, et al.
Publicado: (2016)

Precipitated sdLDL: An easy method to estimate LDL particle size
por: Fernández‐Cidón, Bárbara, et al.
Publicado: (2020)

LDL apheresis in a woman with severe heterozygous familial hypercholesterolemia. Late, but not too late
por: Mickiewicz, Agnieszka, et al.
Publicado: (2015)

LDL-cholesterol reduction in patients with hypercholesterolemia by modulation of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase
por: Filippov, Sergey, et al.
Publicado: (2014)

Plant sterols–enriched diet decreases small, dense LDL-cholesterol levels in children with hypercholesterolemia: a prospective study
por: Garoufi, Anastasia, et al.
Publicado: (2014)

Prevalence, self-awareness, and LDL cholesterol levels among patients highly suspected as familial hypercholesterolemia in a Japanese community
por: Tada, Hayato, et al.
Publicado: (2020)

LDL‐cholesterol and PCSK9 in patients with familial hypercholesterolemia: influence of PCSK9 variants under lipid‐lowering therapy
por: Hamasaki, Masato, et al.
Publicado: (2021)

Glycated Hemoglobin, Fasting Insulin and the Metabolic Syndrome in Males. Cross-Sectional Analyses of the Aragon Workers’ Health Study Baseline
por: Saravia, Gabriela, et al.
Publicado: (2015)

Is the process of delivery of an individually tailored lifestyle intervention associated with improvements in LDL cholesterol and multiple lifestyle behaviours in people with Familial Hypercholesterolemia?
por: Broekhuizen, Karen, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qid2vfvjc4hcbka9mhamn60cs2